ENO1 and cancer: Given that SA and amoB1 inhibit ENO1 and PKM2 activity in vitro and SA suppresses aerobic glycolysis in vivo, our results raise the possibility that salicylates mediate their anti-cancer and anti-inflammatory effects, at least in part, by suppressing the Warburg effect.